Role of SOX10 Immunohistochemical Expression in Diagnosing Triple Negative Breast Cancer and Its Correlation With Clinicopathological Features

被引:1
作者
Tariq, Muhammad Usman [1 ]
Siddiqui, Muhammad Afnan [2 ]
Din, Nasir Ud [3 ]
Kayani, Naila [3 ]
机构
[1] Al Hada Armed Forces Hosp, Histopathol, Taif, Saudi Arabia
[2] Indus Hosp & Hlth Network, Histopathol, Karachi, Pakistan
[3] Aga Khan Univ Hosp, Pathol & Lab Med, Karachi, Pakistan
关键词
tumor infiltrating lymphocytes; immunohistochemistry; tnbc; triple negative breast cancer; sox10; MELANOCYTIC NEOPLASMS; CARCINOMA; FREQUENCY; UTILITY;
D O I
10.7759/cureus.59276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Triple -negative breast cancer (TNBC) poses a diagnostic challenge for histopathologists due to the reduced frequency of breast -specific markers. SOX10 has emerged as a useful diagnostic marker for TNBC. The aim of our study was to determine the frequency of SOX -10 immunohistochemical (IHC) expression in our cohort and assess its correlation with clinicopathological and histological features. Materials and methods: We included 72 primary TNBC cases. Specimens included tru-cut biopsies and excision specimens. We stained whole slide sections of these specimens with SOX10 antibody and calculated its frequency (%) of expression and H -score. We applied the chi-square test to assess the correlation between SOX10 expression and clinicopathological and histological features such as the patient's age, specimen type, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, tumor -infiltrating lymphocytes (TILs), necrosis, calcification, lymphovascular invasion (LVI), lymph node involvement, T stage, and N stage. Results: SOX10 expression was observed in 42 (58.3%) cases with a median H -score of 57.5. The expression was significantly higher in tru-cut biopsy specimens as compared to excision specimens (73.5 vs 41.7%) and TILs negative tumors as compared to TILs positive tumors (64.3% vs 27.3). Metaplastic carcinoma showed reduced expression when compared with non-metaplastic tumors (35.7% vs 63.8%), but statistical significance was not achieved. No correlation was observed with the patient's age, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, necrosis, calcification, LVI, lymph node involvement, T stage, and N stage. Conclusion: SOX10 was expressed in more than half of the TNBC cases of our study which not only highlights its diagnostic utility but advocated its application in combination with other breast -specific markers. The expression didn't correlate with the majority of clinicopathological and histological features, but correlation with tru-cut biopsy specimens and absence of TILs draws attention towards possible roles of proper fixation and host immunity, respectively.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma
    Harbhajanka, Aparna
    Chahar, Satyapal
    Miskimen, Kristy
    Silverman, Paula
    Harris, Lyndsay
    Williams, Nicole
    Varadan, Vinay
    Gilmore, Hannah
    HUMAN PATHOLOGY, 2018, 80 : 163 - 169
  • [2] Clinicopathological significance of Sox10 expression in triple-negative breast carcinoma
    Jin, Linfang
    Qin, Chenglin
    Qi, Xiaowei
    Hong, Tingting
    Yang, Xiaodong
    Zhu, Xun
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5603 - 5613
  • [3] Expression of SOX10 in Triple-Negative Breast Carcinoma in Pakistan
    Ali, Seemal
    Rathore, Zonaira
    Rafique, Zubaria
    Chughtai, Akhtar S.
    Atiq, Aribah
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [4] Correlation of Clinicopathological Features and LGR5 Expression in Triple-Negative Breast Cancer
    Ogasawara, Souya
    Uehara, Takeshi
    Nakajima, Tomoyuki
    Iwaya, Mai
    Maeno, Kazuma
    Tsuchiya, Shinichi
    Ota, Hiroyoshi
    Ito, Ken-ichi
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 46
  • [5] A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer
    Tozbikian, Gary H.
    Zynger, Debra L.
    HUMAN PATHOLOGY, 2019, 85 : 221 - 227
  • [6] SOX2 GENE EXPRESSION AND ITS ROLE IN TRIPLE NEGATIVE BREAST CANCER TISSUES
    Yao, G. D.
    Niu, Y. Y.
    Chen, K. X.
    Meng, H. X.
    Song, H. T.
    Tian, Z. N.
    Geng, J. S.
    Feng, M. Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (06) : 1399 - 1406
  • [7] Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer
    Jamidi, Shirley K.
    Hu, Jintao
    Aphivatanasiri, Chaiwat
    Tsang, Julia Y.
    Poon, Ivan K.
    Li, Joshua J.
    Chan, Siu-Ki
    Cheung, Sai-Yin
    Tse, Gary M.
    HISTOPATHOLOGY, 2020, 77 (06) : 936 - 948
  • [8] Immunohistological Expression of SOX-10 in Triple-Negative Breast Cancer: A Descriptive Analysis of 113 Samples
    Kriegsmann, Katharina
    Flechtenmacher, Christa
    Heil, Joerg
    Kriegsmann, Joerg
    Mechtersheimer, Gunhild
    Aulmann, Sebastian
    Weichert, Wilko
    Sinn, Hans-Peter
    Kriegsmann, Mark
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 10
  • [9] High frequency of p16 and SOX10 coexpression but not androgen receptor expression in triple-negative breast cancers
    Yoon, Esther C.
    Wilson, Parker
    Zuo, Tao
    Pinto, Marguerite
    Cole, Kimberly
    Harigopal, Malini
    HUMAN PATHOLOGY, 2020, 102 : 13 - 22
  • [10] TRPS1, GATA3, and SOX10 expression in triple- negative breast carcinoma
    Yoon, Esther C.
    Wang, Gang
    Parkinson, Bryce
    Huo, Lei
    Peng, Yan
    Wang, Jing
    Salisbury, Taylor
    Wu, Yun
    Chen, Hui
    Albarracin, Constance T.
    Resetkova, Erika
    Middleton, Lavinia P.
    Krishnamurthy, Savitri
    Gan, Qiong
    Sun, Hongxia
    Huang, Xiao
    Shen, Tiansheng
    Chen, Wei
    Parwani, Anil V.
    Sahin, Aysegul A.
    Li, Zaibo
    Ding, Qingqing
    HUMAN PATHOLOGY, 2022, 125 : 97 - 107